Inmaculada Hernandez, PharmD, PhD

  • Assistant Professor, Pharmacy and Therapeutics
  • Associate Director, Center for Pharmaceutical Policy and Prescribing

Inmaculada (Inma) Hernandez joined the faculty of the University of Pittsburgh in 2016, where she serves as an Assistant Professor of Pharmacy and Therapeutics and as Associate Director of the Center for Pharmaceutical Policy and Prescribing. Dr. Hernandez has published over 50 peer-reviewed manuscripts, including 42 as first or senior author. These articles have been published in top-tier medical journals, including JAMA, Annals of Internal Medicine, JAMA Internal Medicine, JAMA Oncology, Health Affairs, and Stroke, and have been featured in the main media outlets, including NPR, Forbes, ABC, CNBC, BBC, Fox News, or Bloomberg. Hernandez was recently awarded a K01 career development award from the National Heart, Lung and Blood Institute to study patient and system-level determinants of oral anticoagulation use in atrial fibrillation (K01HL142847). She is also the PI of a small grant from the Alzheimer’s Association on the use of data mining techniques to predict side effects of anti-dementia drugs (AARGD-17-500234). She was recently recognized on the Forbes 30 under 30 list as a young leader in healthcare research. She has also been awarded the national Seema S. Sonnad Emerging Leader in Managed Care Research Award and the Rho Chi Society Outstanding Scholarly Contribution Award, among other honors. She has achieved Fellowship status in the American College of Cardiology and the American Heart Association.

Hernandez’s research program is built at the intersection of pharmaceutical health services and outcomes research, pharmacoepidemiology, pharmacoeconomics and pharmaceutical policy. Specifically, her current research has 3 main areas of focus:
• Real-world use and outcomes of oral anticoagulation therapy in stroke prevention in atrial fibrillation.
• Use of large data sets, advanced data mining techniques and comparative effectiveness research to predict and compare outcomes of antidementia medications.
• Study of pharmaceutical pricing trends and pricing strategies in response to market disruptions.

Prior to joining Pitt Pharmacy, Dr. Hernandez earned her PharmD from the University of Navarra (Spain) in 2013, and she completed her clinical training in the North Middlesex University Hospital and Green Light Pharmacy, both in London (UK). Upon graduation, she was selected as 1 in 48 among thousands of graduates in Spain across all disciplines to receive a “La Caixa” fellowship. This prestigious fellowship supported her PhD studies in Health Services Research and Policy at the University of Pittsburgh Graduate School of Public Health. Completed in 3 years, the research conducted during her PhD yielded 11 first-author peer-reviewed publications and 2 press releases. Published in JAMA Internal Medicine and Stroke, some of these studies were among the first to provide evidence on the real-world outcomes of non-vitamin K antagonist oral anticoagulants after their approval, and were featured in media outlets around the world.

Education & Training

  • PhD in Health Services Research and Policy - University of Pittsburgh, 2016
  • PharmD - University of Navarra- Pamplona, Spain, 2013
  • MS in Health Economics and Pharmacoeconomics - Pompeu i Fabra University - Barcelona, Spain, 2013